Skip to content

TEAS-induced Analgesia: Dual vs Single Acupoints

CompletedNot applicableNCT02543580
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

The purpose of this study is to evaluate the effects of transcutaneous electric acupoint stimulation(TEAS) at single acupoint or dual acupoints on opioid consumption and postoperative pain in patients undergoing radical mastectomy

Study details

Official title
Transcutaneous Electrical Acupoint Stimulation Decreases Remifentanil Consumption and Postoperative Pain in Patients Undergoing Radical Mastectomy: Dual Acupoints Versus Single Acupoint in a Prospective Randomized Controlled Trial
Conditions
Interventions
  • Other: transcutaneous electric acupoint stimulation
  • Other: electrode attached but no stimulation
Sponsor
Xijing Hospital
Start date
2015-07
Primary completion
2015-12
Sex
All
Age range
from 18 Years to 65 Years
Results posted
No results posted in this snapshot
Countries
China
Total sites listed
1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * patients aged from 18 to 65 yrs * body mass index (BMI) of 18 to 30 kg/m2 * elective radical mastectomy under general anesthesia Exclusion Criteria: * contradictions to electric stimulation * difficulties in communication * histories of general anesthesia, drug or alcohol abuse or addiction * cardiac dysfunction or severe hypertension, confirmed hepatic dysfunction and renal impairment * participants recruited into other clinical trials during last three months

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02543580